logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
S

Simon Spazzapan

oncologia medica e prevenzione oncologica centro di riferimento oncologico (cro)
H指数:23
被引数:2,972

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

DonnaRosa Project: Exploring Informal Communication Practices Among Breast Cancer Specialists

DonnaRosa 项目：探索乳腺癌专家之间的非正式沟通实践

Current Oncology 2025, Vol. 32, Page 704
IF3.4
2025-12-140
OAAI
Antonella Ferro; Flavia Atzori; Catia Angiolini; Michela Bortolin; Laura Cortesi; Alessandra Fabi; Elena Fiorio; Ornella Garrone; Lorenzo Gianni; Monica Giordano; Laura Merlini; Marta Mion; Luca Moscetti; Donata Sartori; Maria Giuseppa Sarobba; Simon Spazzapan; Roberto Lusardi
Prognostic impact of liquid biopsy (LB) biomarkers at relapse on second-line (2L) treatment (Tx) after progression to endocrine therapy (ET) in metastatic breast cancer (mBC): Ancillary analysis of the MAGNETIC.1 study

内分泌治疗（ET）进展后转移性乳腺癌（mBC）复发时液体活检（LB）生物标志物对二线（2L）治疗（Tx）的预后影响：MAGNETIC.1研究的附加分析

ANNALS OF ONCOLOGY
IF65.4
2024-09-010
PRE
Dri, A.; Foffano, L.; Molteni, E.; Franzoni, A.; Lay, L.; Cucciniello, L.; Da Ros, L.; Buriolla, S.; Bolzonello, S.; Noto, C.; Russo, S.; Spazzapan, S.; Nascimbeni, E.; Pasto, B.; Bonotto, M.; Minisini, A. M. M.; Damante, G.; Belletti, B.; Gerratana, L.; Puglisi, F.
Assessing interstitial lung disease (ILD) risk in metastatic breast cancer (MBC): A comprehensive meta and network analysis of antibody-drug conjugates (ADCs) compared to available treatment options beyond first-line (1L)

评估转移性乳腺癌(MBC)中特发性肺间质病变(ILD)风险：抗体偶联物(ADCs)与现有一线(1L)后治疗方案比较的全面Meta分析和网络分析

ANNALS OF ONCOLOGY
IF65.4
2024-09-010
PRE
Cucciniello, L.; Giudici, F.; Di Nardo, P.; Dri, A.; Della Rossa, S.; Zottarelli, E.; Noto, C.; Foffano, L.; Pasto, B.; Bolzonello, S.; Da Ros, L.; Cudia, G.; Nascimbeni, E.; Lisanti, C.; Spazzapan, S.; Serraino, D.; Gerratana, L.; Puglisi, F.
Differential dynamics of fragmentomic and epigenetic circulating tumor DNA (ctDNA) features in first-line Palbociclib and Ribociclib treatment for Hormone Receptor (HR) positive, HER2 negative metastatic breast cancer (MBC)
CANCER RESEARCH
IF16.6
2024-05-020
PRE
Noto, Claudia; Cucciniello, Linda; Molteni, Elisabetta; Bolzonello, Silvia; Franzoni, Alessandra; Da Ros, Lucia; Buriolla, Silvia; Dri, Arianna; Foffano, Lorenzo; Spazzapan, Simon; Russo, Stefania; Pasto, Brenno; Cudia, Giulia; Targato, Giada; Della Rossa, Serena; Bonotto, Marta; Minisini, Alessandro Marco; Damante, Giuseppe; Belletti, Barbara; Gerratana, Lorenzo
Unraveling the influence of progesterone receptor status on endocrine therapy sensitivity: insight from epigenetic and fragmentomics ctDNA profiling in estrogen receptor positive, HER2 negative metastatic breast cancer (MBC)
CANCER RESEARCH
IF16.6
2024-05-020
PRE
Foffano, Lorenzo; Molteni, Elisabetta; Dri, Arianna; Franzoni, Alessandra; Cucciniello, Linda; Da Ros, Lucia; Buriolla, Silvia; Bolzonello, Silvia; Noto, Claudia; Russo, Stefania; Spazzapan, Simon; Nascimbeni, Elena; Pasto, Brenno; Targato, Giada; Della Rossa, Serena; Bonotto, Marta; Minisini, Alessandro Marco; Damante, Giuseppe; Belletti, Barbara; Gerratana, Lorenzo; Puglisi, Fabio
Patterns of time-to-progression intervals across clinical and liquid biopsy (LB) features in hormone receptor-positive (HR+) HER2-negative (HER2-) metastatic breast cancer (MBC) patients (pts) treated with first-line endocrine therapy (ET)
ANNALS OF ONCOLOGY
IF65.4
2023-10-010
OA
Cucciniello, L.; Noto, C.; Bolzonello, S.; Molteni, E.; Da Ros, L.; Pasto, B.; Franzoni, A.; Spazzapan, S.; Russo, S.; Foffano, L.; Buriolla, S.; Targato, G.; Allegri, L.; Dri, A.; Della Rossa, S.; Bonotto, M.; Damante, G.; Belletti, B.; Gerratana, L.; Puglisi, F.
Homologous recombination deficiency, RB-loss gene signatures, intrinsic subtype and response to neoadjuvant treatment in HR+/HER2-early breast cancer: a correlative analysis of two phase II trials
CANCER RESEARCH
IF16.6
2023-03-010
PRE
Griguolo, Gaia; Miglietta, Federica; Pare, Laia; Generali, Daniele G.; Frassoldati, Antonio; Musolino, Antonino; Spazzapan, Simon; Vernaci, Grazia; Giarratano, Tommaso; Lo Mele, Marcello; Bisagni, Giancarlo; Piacentini, Federico; Tagliafico, Enrico; Cagossi, Katia; Schiavi, Francesca; Pinato, Claudia; Prat, Aleix; Guarneri, Valentina; Dieci, Maria Vittoria
Clinical and biological predictors of lymph node involvement in patients with early breast cancer for adjuvant treatment personalization
CANCER RESEARCH
IF16.6
2023-03-010
PRE
Pivetta, Tania; Pasto, Brenno; Urbani, Martina; Benozzi, Elisabetta; De Pascalis, Nicola; Perin, Tiziana; Mileto, Mario; Pasquotti, Bruno; Piccoli, Erica; Vinante, Lorenzo; Bampo, Chiara; Bolzonello, Silvia; Garutti, Mattia; Nicoloso, Milena; Corsetti, Serena; Scalone, Simona; da Ros, Lucia; di Nardo, Paola; Lisanti, Camilla; Spazzapan, Simon; Belletti, Barbara; Bartoletti, Michele; Gerratana, Lorenzo; Massarut, Samuele; Puglisi, Fabio
Safety and Efficacy of Ribociclib in Combination with Letrozole in Patients with HR+, HER2-Advanced Breast Cancer: Results from the Italian Subpopulation of Phase 3b CompLEEment-1 Study

瑞博西尼联合来曲唑治疗HR HER2-Advanced乳腺癌患者的安全性和有效性: 来自意大利3b期CompLEEment-1研究亚群的结果

TARGETED ONCOLOGY
IF4
2022-09-244
OAAI
De Laurentiis, Michelino; Caputo, Roberta; Mazza, Manuelita; Mansutti, Mauro; Masetti, Riccardo; Ballatore, Zelmira; Torrisi, Rosalba; Michelotti, Andrea; Zambelli, Alberto; Ferro, Antonella; Generali, Daniele; Vici, Patrizia; Coltelli, Luigi; Fabi, Alessandra; Marchetti, Paolo; Ballestrero, Alberto; Spazzapan, Simon; Frassoldati, Antonio; Sarobba, Maria Giuseppina; Grasso, Donatella; Zamagni, Claudio
Randomized comparison of adjuvant aromatase inhibitor exemestane (E) plus ovarian function suppression (OFS) vs tamoxifen (T) plus OFS in premenopausal women with hormone receptor-positive (HR plus ) early breast cancer (BC): update of the combined TEXT and SOFT trials
CANCER RESEARCH
IF16.6
2022-02-154
PRE
Regan, Meredith M.; Walley, Barbara A.; Fleming, Gini F.; Francis, Prudence A.; Colleoni, Marco A.; Lang, Istvan; Gomez, Henry L.; Tondini, Carlo A.; Burstein, Harold J.; Goetz, Matthew P.; Ciruelos, Eva M.; Stearns, Vered; Bonnefoi, Herve R.; Martino, Silvana; Geyer, Charles E., Jr.; Chini, Claudio; Minisini, Alessandro M.; Spazzapan, Simon; Ruhstaller, Thomas; Winer, Eric P.; Ruepp, Barbara; Loi, Sherene; Coates, Alan S.; Goldhirsch, Aron; Gelber, Richard D.; Pagani, Olivia
First- and second-line treatment strategies for hormone-receptor (HR)-positive HER2-negative metastatic breast cancer: A real-world study

激素受体 (HR) 阳性HER2-negative转移性乳腺癌的一线和二线治疗策略: 一项真实世界研究

BREAST
IF7.9
2021-06-0121
OAAI
Basile, Debora; Gerratana, Lorenzo; Corvaja, Carla; Pelizzari, Giacomo; Franceschin, Giorgia; Bertoli, Elisa; Palmero, Lorenza; Zara, Diego; Alberti, Martina; Buriolla, Silvia; Da Ros, Lucia; Bonotto, Marta; Mansutti, Mauro; Spazzapan, Simon; Cinausero, Marika; Minisini, Alessandro Marco; Fasola, Gianpiero; Puglisi, Fabio

研究方向

暂未获取到该数据
F
Fabio Puglisi
H 指数:59论文数:767被引数:1.6万
L
Lucia Da Ros
H 指数:12论文数:52被引数:1,116
L
Lorenzo Gerratana
H 指数:34论文数:678被引数:4,473
D
Diana Crivellari
H 指数:43论文数:286被引数:8,132
M
Meredith M. Regan
H 指数:95论文数:676被引数:4.2万
R
Richard D. Gelber
H 指数:133论文数:594被引数:9.0万
S
Samuele Massarut
H 指数:36论文数:183被引数:1.7万
R
Riccardo Dolcetti
H 指数:60论文数:476被引数:1.3万
T
Tiziana Perin
H 指数:32论文数:186被引数:4,012
E
Elena Muraro
H 指数:22论文数:95被引数:1,412